tirzepatide english Most people think GLP-1s are

Further studies are needed to identify how to support people using these drugs, and to identify cost-effective strategies for long-term weight control

Wegovy is a once-weekly injection in the tummy, thigh, or upper arm The dose is started low and increased gradually to reduce side effects It is used alongside a reduced-calorie diet and increased physical activity for best results Clinical trials have shown that Wegovy offers a number of health benefits beyond weight loss alone: Heart health in the SELECT trial, people taking Wegovy had a 20% lower risk of serious heart events such as heart attack and stroke

It is the first weight-management drug approved since the FDA approved liraglutide (Saxenda) in 2014 for chronic weight management

Temperature swings accelerate degradation even within the safe range

But because the landscape around compounded GLP-1 medications has shifted dramatically since the FDA resolved the semaglutide shortage in February 2025, and what was once a straightforward decision now involves regulatory gray areas, legal battles, and quality control questions that most people never expected to navigate